2-DG Drug: How will DRDO drug 2-deoxy-D-glucose launch work in the treatment of corona? Know everything

DRDO Covid-19 Drug: The first batch of 2-DG (2-deoxy-D-glucose) drug for the treatment of coronavirus patients has been launched today.

DRDO Covid-19 Drug: The first batch of 2-DG (2-deoxy-D-glucose) drug for the treatment of coronavirus patients has been launched today. This 2-DG drug has been manufactured by the Defense Research and Development Organization (DRDO) in collaboration with Dr. Reddy’s Laboratories. Defense Minister Rajnath Singh and Health Minister Dr. Harsh Vardhan have launched this drug of DRDO on Monday. It is believed that soon after the launch, these patients will start getting.

Can become a game changer

DCGI approved the emergency use of this medicine only last week. This drug is being seen as a game-changer in the fight against this epidemic, as it helps in rapid recovery of hospitalized patients and also reduces oxygen support. According to media reports, its 10,000 dose has been prepared. The special thing about this medicine is that it comes in a packet in the form of powder and it has to be dissolved in water and drink.

Delhi: Defence Minister Rajnath Singh and Union Health Minister Dr Harsh Vardhan release first batch of Anti-COVID drug 2DG developed by DRDO pic.twitter.com/gUu6IuYlrT

– ANI (@ANI) May 17, 2021

Who has made this medicine

The 2DG drug has been developed by DRDO’s Institute of Nuclear Medicine and Allied Sciences (INMAS) in association with Dr. Reddy’s Laboratories. Only Dr. Reddy’s Lab will make this medicine for the general public. This medicine will be available in the form of a powder. Last year, when the first wave of COVID-19 started in India, since then scientists of INMAS started working on it. In May 2020, the Drug Controller General of India (DCGI) approved the Phase 2 trial on COVID patients of this drug. It was revealed in the trial that the drug COVID is safe for the patients and also helps in recovery.

Where did the trial take place

DCGI approved the emergency use of this drug based on the trial data. The trial was carried out on 220 patients between December 2020 and March 2021 in 27 Covid-19 hospitals in Delhi, Uttar Pradesh, West Bengal, Gujarat, Rajasthan, Maharashtra, Andhra Pradesh, Telangana, Karnataka and Tamil Nadu.

How does medicine work

2DG is actually an altered form of the 2DG molecule that treats tumors, cancer cells. It was found in the trial that not only is 2DG COVID effective in treating patients, the admission in the hospital also reduces the dependence on oxygen of the patients. Permission to use this medicine like secondary medicine has been given. This drug is largely like glucose, but not glucose. On taking the medicine dose, the virus will take this glucose analog and get trapped in it. As a result, the virus will not be able to make its copies, that is, its growth will stop.